Keyphrases
Placebo-controlled
100%
Alzheimer's Disease
100%
HF-rTMS
100%
H-coil
100%
Repetitive Transcranial Magnetic Stimulation (rTMS)
80%
ADAS-Cog
60%
Sham
40%
Phase II Trial
20%
Disease Stage
20%
Group Differences
20%
Neuronal Structure
20%
Acute Myocardial Infarction
20%
End of Treatment
20%
Patient Adherence
20%
Clinical Global Impression
20%
Temporal Lobe
20%
Fronto
20%
Early Disease
20%
Beck Depression inventory-II (BDI-II)
20%
Word Recognition
20%
Missing Data
20%
4-point
20%
Cognitive Training
20%
Start of Treatment
20%
Mini-Mental State Examination
20%
Recognition Task
20%
Neuropsychological Data
20%
Point Group
20%
Neuropsychological Assessment
20%
Real Groups
20%
Alzheimer's Disease Assessment Scale
20%
Medicine and Dentistry
Placebo
100%
Alzheimer's Disease
100%
Repetitive Transcranial Magnetic Stimulation
100%
Mini-Mental State Examination
60%
Side Effect
40%
Disease
20%
Arm
20%
Phase II Trials
20%
Acute Heart Infarction
20%
Patient Compliance
20%
Diagnostic Error
20%
Temporal Lobe
20%
Clinical Global Impression
20%
Beck Depression Inventory
20%
Alzheimer Disease Assessment Scale
20%
Word Recognition
20%
Neuroscience
Transcranial Magnetic Stimulation
100%
Alzheimer's Disease
100%
Placebo
100%
Myocardial Infarction
16%
Temporal Lobe
16%
Beck Depression Inventory
16%
Neuropsychological Assessment
16%
Word Recognition
16%
Pharmacology, Toxicology and Pharmaceutical Science
Alzheimer's Disease
100%
Placebo
100%
Side Effect
33%
Disease
16%
Phase II Trials
16%
Acute Heart Infarction
16%
Psychology
Alzheimer's Disease
100%
Mental State
16%
Myocardial Infarction
16%
Misdiagnosis
16%
Beck Depression Inventory
16%
Word Recognition
16%
Neuropsychological Assessment
16%